IRADIMED CEO Roger Susi Sells Shares via Trust as Part of Systematic Liquidation Plan

Roger E. Susi, CEO and Chairman of IRADIMED (NASDAQ:IRMD), sold 7,500 shares indirectly through a trust on May 26-27, 2026, under a Rule 10b5-1 trading plan. The transaction aligns with his pattern of smaller block sales as he systematically reduces holdings following the company's strong one-year performance.

By Seena Hassouna, The Motley Fool Tue, June 2, 2026 at 3:29 PM GMT+3 4 min read · Yahoo Finance · June 2, 2026, 12:29 UTC

Tickers: $IRMD

Topics: CEO sale SEC Form 4 filing stock ownership

Read the full article at Yahoo Finance

More World news

Jensen Huang Resigns as Nvidia CEO Amid Personal Conduct Controversies and China Export Investigations Motley Fool · November 12, 2026, 18:56 UTC
The Adecco Group Reports Q3 2026 Growth Driven by Temporary Staffing and Margin Expansion PR Newswire · November 12, 2026, 18:54 UTC
Twist Bioscience Projects FY2027 Revenue Between $550M and $560M Seeking Alpha · November 12, 2026, 18:50 UTC
Dixie Group Reports Q3 Sales Growth Amid Margin Pressure and Future Cost-Reduction Targets Seeking Alpha · November 12, 2026, 18:50 UTC
Data I/O Corporation Targets Rapid V-TEK Synergy Realization Amid $80 Million M&A Pipeline Seeking Alpha · November 12, 2026, 18:50 UTC
Leatt Corporation Reports 43% Increase in Q3 Revenue to $20.46 Million Seeking Alpha · November 12, 2026, 18:50 UTC
Parsons Reports Strong Third Quarter Results Driven by High-Margin Product Shift Motley Fool · November 12, 2026, 18:45 UTC
C.H. Robinson Reports Q3 2026 Earnings Driven by AI Efficiency and Margin Expansion Motley Fool · November 12, 2026, 18:45 UTC
Baker Hughes Raises Guidance Amid Surging Data Center Power Demand Motley Fool · November 12, 2026, 18:45 UTC
California Supreme Court to Rule on Insurance Overcharge Liability Under Proposition 103 PR Newswire · November 12, 2026, 18:44 UTC